Full Text
The Full Text of this article is available as a PDF (89.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Coster T. S., Killeen K. P., Waldor M. K., Beattie D. T., Spriggs D. R., Kenner J. R., Trofa A., Sadoff J. C., Mekalanos J. J., Taylor D. N. Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet. 1995 Apr 15;345(8955):949–952. doi: 10.1016/s0140-6736(95)90698-3. [DOI] [PubMed] [Google Scholar]
- Falklind S., Stark M., Albert M. J., Uhlén M., Lundeberg J., Weintraub A. Cloning and sequence of a region of Vibrio cholerae O139 Bengal and its use in PCR-based detection. J Clin Microbiol. 1996 Dec;34(12):2904–2908. doi: 10.1128/jcm.34.12.2904-2908.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaper J. B., Levine M. M. Recombinant attenuated Vibrio cholerae strains used as live oral vaccines. Res Microbiol. 1990 Sep-Oct;141(7-8):901–906. doi: 10.1016/0923-2508(90)90128-d. [DOI] [PubMed] [Google Scholar]
- Taylor D. N., Killeen K. P., Hack D. C., Kenner J. R., Coster T. S., Beattie D. T., Ezzell J., Hyman T., Trofa A., Sjogren M. H. Development of a live, oral, attenuated vaccine against El Tor cholera. J Infect Dis. 1994 Dec;170(6):1518–1523. doi: 10.1093/infdis/170.6.1518. [DOI] [PubMed] [Google Scholar]